glp 1 with dpp 4 Receptor Agonists and Inhibitors Mechanism of Action Cardiovascular effects of DPP-4 inhibition:
Description
Pratley RE, Nauck M, Bailey T, Montanya E, Cuddihy R, Filetti S, et al
Some of these medications are pure GLP-1 receptor agonists, as they only activate the GLP-1 receptor
H., Hoefer J., Bolz S
Diabetology & Metabolic Syndrome
A 7.6 percentage point gap in responder rate, with statistical superiority rather than just non-inferiority, is a meaningfully different result than comparable to existing options its evidence the new formulation may genuinely outperform one of the category leaders, not just match it
Diabetes 66: 372384, 2017
